Michelle Seitz

Insider Reports History

Entity
Individual
Location
C/O Sana Biotechnology, Inc., 188 East Blaine Street, Suite 400, Seattle, WA
Signature
/s/ Cecilia Aza, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Michelle Seitz:

Stock Role Class Num Shares Value Price $ Report Date Ownership
MSCI Inc. Director Common Stock 286 $134K $470.03 Aug 5, 2024 Direct
Sana Biotechnology, Inc. Director Stock Option (Right to Buy) 65K Jun 6, 2024 Direct

Insider Reports Filed by Michelle Seitz

Symbol Company Period Transactions Value $ Form Type Date Filed Role
MSCI MSCI Inc. Aug 5, 2024 1 $0 4 Aug 7, 2024 Director
MSCI MSCI Inc. Aug 5, 2024 0 $0 3 Aug 7, 2024 Director
SANA Sana Biotechnology, Inc. Jun 6, 2024 1 $0 4/A Jul 15, 2024 Director
SANA Sana Biotechnology, Inc. Jun 6, 2024 1 $0 4 Jun 7, 2024 Director
SANA Sana Biotechnology, Inc. Jun 8, 2023 1 $0 4 Jun 9, 2023 Director
SANA Sana Biotechnology, Inc. Jun 6, 2022 1 $0 4 Jun 8, 2022 Director